Engflag

Lactomed

Quick links to important sections

Lactomed

Lactomed_DE

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lactomed

What is Lactomed?

Lactomed is an osmotic laxative containing the active substance lactulose, a synthetic derivative of lactose. It is primarily used to manage chronic constipation and to facilitate a softer stool when medically necessary, such as in the presence of hemorrhoids or following anal or colonic surgery.

Mechanism of Action

Lactulose is a disaccharide that is not absorbed into the bloodstream from the digestive tract. Upon reaching the colon, it is broken down by resident bacteria into organic acids, such as lactic and acetic acids. This process results in several physiological effects:

  • Osmotic Effect: The presence of these acids increases the osmotic pressure within the bowel, drawing water into the intestinal lumen.
  • Stool Softening: The increased water content increases the volume of the stool and softens its consistency.
  • Peristalsis Stimulation: The increased volume naturally stimulates the movement of the intestinal muscles, facilitating the passage and evacuation of stool.

In higher doses, Lactomed is also utilized in the management of hepatic encephalopathy. In this context, the acidification of the colonic contents helps to trap ammonia in the form of ammonium ions, which are then expelled from the body, thereby lowering systemic ammonia levels.

Regulatory References

  1. Lactulose: MedlinePlus Drug Information

What side effects are possible with Lactomed?

Possible Side Effects and Safety Information

The safety profile of Lactomed, which contains the active ingredient Lactulose, is defined by regulatory documents based largely on its osmotic and fermentative action in the colon, primarily affecting the Gastrointestinal System. Side effects are officially classified by frequency.

Frequency-Classified Adverse Reactions

Frequency Classification Adverse Reactions (System-Organ Class)
Very Common (ge 1/10) Flatulence (Gastrointestinal Disorders)
Common (ge 1/100 to < 1/10) Abdominal pain, Diarrhoea (Gastrointestinal Disorders)
Uncommon (ge 1/1,000 to < 1/100) Nausea, Vomiting (Gastrointestinal Disorders)
Frequency Not Known Hypersensitivity reactions (Immune System Disorders)

Dose- and Duration-Related Safety Patterns

Flatulence is commonly experienced during the initial phase of treatment and often resolves with continued use. Diarrhoea and the serious consequences associated with it are typically linked to excessive dosage or prolonged, unmonitored high-dose exposure. Serious adverse reactions, specifically severe dehydration and electrolyte imbalance (Metabolism and Nutrition Disorders), are documented as a consequence of persistent, unmanaged diarrhoea.

Regulatory Safety Considerations

The medicine is subject to several safety restrictions defined in official labeling. It is contraindicated in patients with conditions such as known or suspected Gastrointestinal Obstruction, Galactosaemia, or acute Abdominal Pain of undetermined origin. Special caution and monitoring are noted for the paediatric population and for patients treated for Hepatic Encephalopathy, who may require higher doses, increasing the risk of electrolyte disturbance.

Overdose and Emergency Response

Lactomed Overdose and When to Seek Help

The official regulatory documents define the overdose profile of Lactomed (Lactulose) strictly based on the physiological consequences of excessive osmotic activity. The section focuses on the required emergency actions and managing metabolic risks.

Documented Manifestations

The most frequently documented clinical signs expected in the event of overdosage are severe diarrhea and abdominal cramps. These presentations represent the primary effects of an excessively high dose, and the severity dictates the required emergency response.

Severe Consequences and Actions

The most significant systemic risk is not from the substance itself, but from the resultant severe fluid and electrolyte imbalance. Prolonged and excessive fluid loss, such as through persistent diarrhea, can lead to serious conditions including Hypokalemia (low potassium) and Hypernatremia (high sodium).

Mandated Emergency Action: Upon recognizing signs of overdosage, the required action is the immediate termination of the medication or dose reduction.

When to Seek Urgent Help: Immediate medical attention must be sought when fluid loss becomes excessive and persistent, as this requires professional correction of electrolyte disturbances and symptomatic and supportive treatment.

Overdose Management and Constraints

Treatment is always defined as symptomatic and supportive. Regulatory statements confirm that no specific antidote is known, and available data concerning dialysis procedures are not present. Furthermore, official labeling notes that special consideration, including periodic monitoring of serum electrolytes, is required for elderly or debilitated patients on prolonged therapy due to their vulnerability to fluid loss complications.

Therapeutic Uses of Lactomed

Lactomed is designed to offer symptomatic support for a range of common gastrointestinal complaints. Its primary role is to assist in the management of mild to moderate intestinal discomfort, specifically aiming to ease temporary feelings of bloating, gas, and abdominal unease. This medicine is considered an additional option in the therapeutic management of digestive symptoms.

It may also be considered in the context of certain chronic conditions, including Irritable Bowel Syndrome (IBS) and non-specific functional bowel disturbances. By addressing these discomforts, Lactomed helps maintain overall digestive function and supports a sense of daily wellness.

Quick Fact: Support for Intestinal Discomfort

Eligibility and Restrictions for Use

Who can and cannot use Lactomed?

The eligibility for using Lactomed (Lactulose) is defined by its official regulatory profile, which outlines absolute restrictions based on specific metabolic and gastrointestinal conditions.

Populations Who Must Not Use (Contraindicated)

Use is contraindicated and absolutely prohibited for individuals with Galactosaemia or those requiring a strict low galactose diet due to the drug’s sugar composition. It is also contraindicated in the presence of Gastrointestinal (GI) obstruction, digestive perforation, or any high risk of perforation, including acute inflammatory bowel diseases like ulcerative colitis, as stated in regulatory labels.

Eligibility and Restrictions

Population Group Official Regulatory Status
Adults and Older Adults Generally eligible for use. No special dosage adjustments are required for patients with hepatic or renal impairment in standard use.
Pregnancy and Lactation Use is permitted. Regulatory data indicates no anticipated effects on the fetus or infant due to negligible systemic absorption.
Pediatric Population Use in children, infants, and babies is considered exceptional and is not recommended without medical supervision to prevent disruption of normal defecation reflexes.
Diabetes Mellitus Requires caution during use, particularly with high doses used for Hepatic Encephalopathy, as this may affect blood sugar levels.

Eligibility criteria are determined by government health authorities and focus strictly on these labeled population restrictions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations and Restrictions

The interaction profile for Lactomed (Lactulose) is defined by its non-systemic action. Use of Lactomed is strictly restricted for patients requiring a low galactose diet (such as those with Galactosemia) because the product contains components of lactose and galactose.

Drug and Substance Interactions

Co-administration of nonabsorbable antacids is documented to potentially reduce the efficacy of Lactomed by inhibiting the necessary decrease in colonic pH. The official label notes that using other oral laxatives concurrently is discouraged, as the resulting loose stools may obscure the determination of the correct dose required for the primary treatment. A specific interaction is noted with Dichlorphenamide, which may increase the risk of metabolic acidosis if severe and persistent diarrhea is present due to either agent.

Procedural and Administration Constraints

A significant procedural restriction is documented for patients undergoing electrocautery procedures (like proctoscopy or colonoscopy). Due to the theoretical hazard posed by hydrogen gas accumulation (a fermentation product of Lactulose) and the risk of an explosive reaction, a thorough bowel cleansing with a non-fermentable solution is required prior to the procedure. For elderly or debilitated patients receiving long-term Lactomed therapy (over six months), periodic measurement of serum electrolytes is necessary.

Mechanism of Action

Lactulose operates through a non-systemic dual mechanism entirely localized within the colon, relying on both physical principles and biochemical interactions with the resident colonic flora.

Osmotic Fluid Dynamics and Motility Modulation

The core laxative mechanism is initiated by Lactulose acting as an osmotic agent in the intestinal lumen, drawing water from the surrounding tissues due to its non-absorbable nature. This action is rapidly compounded when colonic bacteria ferment the molecule into short-chain fatty acids (SCFAs). This cascade both enhances the osmotic effect and lowers the local pH, which physiologically stimulates colonic peristalsis. The mechanistic consequence is increased stool hydration and accelerated transit velocity.

Chemical pH Modulation and Toxin Trapping

The SCFA production causes significant colonic acidification, creating a chemically altered environment. This pH reduction is crucial for the ion-trapping mechanism, converting diffusable toxins, such as non-ionized ammonia (NH3), into the ionized, non-absorbable Ammonium ion (NH4^+). This chemical conversion confines the nitrogenous compound within the colon. The final physiological consequence is enhanced fecal nitrogen excretion, which results in the rapid removal of NH4^+ via the accelerated transit.

Dosage and Administration Information

Lactomed is approved for administration via the oral route as a solution and, for acute specialized use, via the rectal route as a retention enema. The solution should be accurately measured using a calibrated device before ingestion. The dose may be taken with or without food and can be mixed with water, milk, or juice to enhance palatability.

Labeled Dosing and Administration

Indication Dosing Pattern Frequency Goal
Constipation Starting dose: 15 mL to 30 mL; Maintenance: 15 mL to 45 mL. Once daily, titrated to 1 to 2 soft stools per day.
Systemic Support (HE) Initial oral dose: 30 mL to 45 mL. Three to four times daily, titrated to 2 to 3 soft stools per day.

The standard frequency for constipation management is once daily, though the systemic support regimen requires multiple times daily dosing initially, followed by frequency reduction once the soft stool goal is met. Dosage for pediatric patients is lower than the adult regimen and is determined based on age or body weight. Rectal administration is reserved for acute systemic scenarios, requiring the 300 mL solution to be diluted before use as an enema in a supervised setting. The standard procedure for a missed dose is to take it as soon as remembered, unless it is close to the next scheduled time; the subsequent dose should not be doubled. This protocol defines the standardized, label-based approach for using the medicine.

Recent Clinical Evidence

Lactomed: Recent Clinical Evidence

Evidence for Chronic Constipation

Numerous Randomized Controlled Trials (RCTs) and Systematic Reviews was studied for use in conditions characterized by fluctuating manifestations like chronic constipation. Research examined outcomes related to physical discomfort, primarily changes in weekly stool frequency and stool consistency. Findings describe patterns related to numerically higher outcomes in the Lactomed group when compared to placebo. However, follow-up durations were limited in many key studies, meaning long-term effects are not fully established.

Evidence for Hepatic Encephalopathy (HE)

A large body of evidence, including RCTs and Meta-Analyses, was studied for this application in patients with cirrhosis. Research examined outcomes related to systemic or functional imbalance, such as blood ammonia levels, mental status scores, and the rate of HE recurrence. The volume of evidence contributes to the research base for this application. However, ethical considerations make it difficult to conduct modern, rigorous placebo-controlled trials for acute HE, and findings were mixed regarding all-cause mortality in some analyses.

Evidence for Functional Bowel Symptoms (e.g., IBS)

Lactomed was evaluated in research contexts involving conditions like Irritable Bowel Syndrome (IBS). Studies monitored outcomes related to physical discomfort and changes in global IBS symptoms. Trials described variable patterns of measurement and the certainty remains low regarding comprehensive outcomes, as the evidence is limited and there is a stated need for larger controlled clinical trials.

Research Gaps and Special Populations

Lactomed was studied for use in older adults and pediatric groups across its primary uses. Research has observed patient responses over defined time intervals, with long-term effects not fully established beyond short-term follow-up periods. Data for certain groups remain insufficient, and the overall evidence quality varies across studies, highlighting areas where more rigorous controlled clinical trials are needed.

Key Studies & References Lactulose - StatPearls (Source used for indications, clinical context, and ethical difficulty of HE placebo trials)

Frequently Asked Questions (FAQ)

Common questions about Lactomed (FAQ)

Q: What is Lactomed used for?

A: Lactomed is indicated for the temporary relief of symptoms associated with lactose intolerance, such as gas, bloating, and diarrhea, following the consumption of dairy products. It is designed to supplement the body's natural ability to break down lactose.

Q: How should I take Lactomed?

A: The label information suggests that Lactomed is generally taken with the first bite of dairy food or drink. It is important to follow the directions provided on the product packaging or consult a healthcare professional for specific guidance on usage.

Q: Can Lactomed be used by children?

A: Whether Lactomed is appropriate for use in children may depend on the specific formulation and the child's age. It is best to consult a pediatrician or other qualified healthcare provider before giving any dietary supplement to a child.

Q: What should I do if I miss a dose?

A: Since Lactomed is typically taken as needed with dairy consumption, the concept of a "missed dose" does not generally apply. If you consume dairy without taking it, you may experience symptoms of lactose intolerance. Do not attempt to "catch up" by taking extra.

Q: Are there any known side effects of Lactomed?

A: When used as directed, Lactomed is generally well-tolerated. Rarely, some individuals might experience mild digestive upset. If you notice any unexpected or severe reactions, you should stop use and speak with a healthcare provider.

How should Lactomed be stored and disposed of?

Storage and Disposal of Lactulose Solution USP (Lactomed)

The official storage profile requires the oral solution to be kept at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F), though a wider range up to 30 C is acceptable. It is mandatory to keep this and all drugs out of the reach of children. The product must not be frozen and must be protected from prolonged high heat and direct light. The solution should be dispensed in a tight, light-resistant container. A normal darkening of color is expected, but the product must not be used if extreme darkening or turbidity develops.

For disposal, the FDA recommends using a drug take-back program. If this is unavailable, the medicine should be mixed with an undesirable substance (like coffee grounds or kitty litter), sealed in a bag or container, and placed in the household trash, as it is not on the FDA flush list.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lactomed found in:

A-Z Index: